Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174187 (US9102637, 222) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174104 (US9102637, 139) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174202 (US9102637, 237) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174160 (US9102637, 195) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174186 (US9102637, 221) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174150 (US9102637, 185) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174196 (US9102637, 231) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174173 (US9102637, 208) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174215 (US9102637, 250) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174185 (US9102637, 220) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174203 (US9102637, 238) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.10 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174155 (US9102637, 190) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174138 (US9102637, 173) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.40 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174211 (US9102637, 246) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174128 (US9102637, 163) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174190 (US9102637, 225) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173989 (US9102637, 24) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.10 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174145 (US9102637, 180) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174130 (US9102637, 165) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174183 (US9102637, 218) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174219 (US9102637, 254) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.80 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174168 (US9102637, 203) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173982 (US9102637, 17) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174225 (US9102637, 260) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173988 (US9102637, 23) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174035 (US9102637, 70) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174224 (US9102637, 259) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174167 (US9102637, 202) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174166 (US9102637, 201) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.60 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174016 (US9102637, 51) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174103 (US9102637, 138) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174081 (US9102637, 116) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174170 (US9102637, 205) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174204 (US9102637, 239) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174169 (US9102637, 204) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174213 (US9102637, 248) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174222 (US9102637, 257) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174154 (US9102637, 189) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174209 (US9102637, 244) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174093 (US9102637, 128) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174152 (US9102637, 187) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173998 (US9102637, 33) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174216 (US9102637, 251) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173978 (US9102637, 13) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174021 (US9102637, 56) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.20 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174153 (US9102637, 188) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.40 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174227 (US9102637, 262) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.40 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173983 (US9102637, 18) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.60 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173976 (US9102637, 11) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.60 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174223 (US9102637, 258) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174005 (US9102637, 40) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.40 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174200 (US9102637, 235) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174101 (US9102637, 136) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174199 (US9102637, 234) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.70 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174214 (US9102637, 249) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10.1 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173977 (US9102637, 12) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10.2 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174197 (US9102637, 232) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10.3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173975 (US9102637, 10) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10.6 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174198 (US9102637, 233) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173995 (US9102637, 30) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10.7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174116 (US9102637, 151) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11.1 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174011 (US9102637, 46) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174048 (US9102637, 83) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12.7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174062 (US9102637, 97) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12.7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174087 (US9102637, 122) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12.8 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174089 (US9102637, 124) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12.9 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174208 (US9102637, 243) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14.8 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174078 (US9102637, 113) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14.8 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174058 (US9102637, 93) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174111 (US9102637, 146) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15.1 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174102 (US9102637, 137) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15.2 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173991 (US9102637, 26) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15.6 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174217 (US9102637, 252) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.9 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174139 (US9102637, 174) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174112 (US9102637, 147) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16.8 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174045 (US9102637, 80) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16.9 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173993 (US9102637, 28) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174221 (US9102637, 256) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 18.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173992 (US9102637, 27) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19.1 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174095 (US9102637, 130) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173967 (US9102637, 2) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19.8 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174057 (US9102637, 92) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20.2 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173981 (US9102637, 16) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20.3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173969 (US9102637, 4) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 21.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174077 (US9102637, 112) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 22.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174000 (US9102637, 35) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 22.7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174086 (US9102637, 121) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24.4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173966 (US9102637, 1) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24.7 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174220 (US9102637, 255) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 26.5 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173974 (US9102637, 9) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 27.2 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM173994 (US9102637, 29) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 27.4 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174030 (US9102637, 65) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 36.3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
TRAF2 and NCK-interacting protein kinase (Homo sapiens (Human)) | BDBM174039 (US9102637, 74) | PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 51.3 | n/a | n/a | n/a | n/a | 7.5 | 25 |
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent | Assay Description The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMS... | US Patent US9102637 (2015) BindingDB Entry DOI: 10.7270/Q2KS6Q9T | |||||||||||
More data for this Ligand-Target Pair |